Financials data is unavailable for this security.
View more
Year on year Novozymes A/S grew revenues 8.45% from 3.83bn to 4.16bn while net income improved 90.84% from 305.80m to 583.60m.
| Gross margin | 54.90% |
|---|---|
| Net profit margin | 14.70% |
| Operating margin | 20.44% |
| Return on assets | 3.82% |
|---|---|
| Return on equity | 5.77% |
| Return on investment | 4.12% |
More ▼
Cash flow in EURView more
In 2025, Novozymes A/S did not generate a significant amount of cash. However, the company earned 1.22bn from its operations for a Cash Flow Margin of 29.38%. In addition the company generated 753.30m cash from financing while 1.97bn was spent on investing.
| Cash flow per share | 19.83 |
|---|---|
| Price/Cash flow per share | 19.21 |
| Book value per share | 178.81 |
|---|---|
| Tangible book value per share | 0.5675 |
More ▼
Balance sheet in EURView more
| Current ratio | 1.74 |
|---|---|
| Quick ratio | 1.04 |
| Total debt/total equity | 0.2751 |
|---|---|
| Total debt/total capital | 0.2157 |
More ▼
Growth rates in EUR
SmartText is unavailable
| Div yield(5 year avg) | 1.46% |
|---|---|
| Div growth rate (5 year) | 4.32% |
| Payout ratio (TTM) | 57.67% |
| EPS growth(5 years) | -1.47 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 11.48 |
More ▼
